(SMG) Scotts Miracle-Gro - Ratings and Ratios
Grass Seed, Lawn Food, Plant Food, Soil Mixes, Grow Lights
SMG EPS (Earnings per Share)
SMG Revenue
Description: SMG Scotts Miracle-Gro
The Scotts Miracle-Gro Company is a leading manufacturer and marketer of lawn, garden, and indoor gardening products, operating through three segments: U.S. Consumer, Hawthorne, and Other. The companys diverse product portfolio includes lawn care products, gardening and landscape products, and hydroponic products, sold under various brands such as Scotts, Miracle-Gro, and Ortho.
To evaluate the companys performance, we can look at key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow. Scotts Miracle-Gros revenue growth has been driven by increasing demand for indoor and hydroponic gardening products, as well as its lawn care and gardening products. The companys gross margin has been affected by factors such as raw material costs, pricing, and product mix.
From a profitability perspective, Scotts Miracle-Gros return on equity (ROE) is currently negative, indicating that the company is not generating sufficient profits to return value to shareholders. However, the companys forward price-to-earnings (P/E) ratio is around 15.80, suggesting that the market expects the company to recover and generate profits in the future.
In terms of valuation, Scotts Miracle-Gros market capitalization is around $4 billion, with a current stock price of $62.09. To determine whether the stock is undervalued or overvalued, we can analyze the companys enterprise value, debt-to-equity ratio, and other metrics. A thorough analysis of these KPIs can help investors make informed decisions about the companys stock.
To further analyze Scotts Miracle-Gros stock, we can examine its dividend yield, payout ratio, and insider activity. The companys dividend yield is an important consideration for income investors, while its payout ratio can indicate the sustainability of its dividend payments. Insider activity, such as buying or selling by executives and directors, can also provide valuable insights into the companys prospects.
SMG Stock Overview
| Market Cap in USD | 3,563m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception | 1992-01-31 |
SMG Stock Ratings
| Growth Rating | -21.5% |
| Fundamental | 57.4% |
| Dividend Rating | 37.2% |
| Return 12m vs S&P 500 | -26.7% |
| Analyst Rating | 4.36 of 5 |
SMG Dividends
| Dividend Yield 12m | 4.24% |
| Yield on Cost 5y | 2.09% |
| Annual Growth 5y | -17.19% |
| Payout Consistency | 95.9% |
| Payout Ratio | 78.3% |
SMG Growth Ratios
| Growth Correlation 3m | -56.6% |
| Growth Correlation 12m | -61.2% |
| Growth Correlation 5y | -64.5% |
| CAGR 5y | 10.05% |
| CAGR/Max DD 3y | 0.21 |
| CAGR/Mean DD 3y | 0.44 |
| Sharpe Ratio 12m | -0.09 |
| Alpha | 0.15 |
| Beta | 0.743 |
| Volatility | 44.46% |
| Current Volume | 603.9k |
| Average Volume 20d | 704.2k |
| Stop Loss | 58 (-3.1%) |
| Signal | -0.81 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (53.1m TTM) > 0 and > 6% of Revenue (6% = 206.4m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -20.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.09% (prev 19.47%; Δ -5.39pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 315.7m > Net Income 53.1m (YES >=105%, WARN >=100%) |
| Net Debt (2.14b) to EBITDA (312.0m) ratio: 6.85 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (58.6m) change vs 12m ago 1.03% (target <= -2.0% for YES) |
| Gross Margin 28.81% (prev 25.49%; Δ 3.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 104.6% (prev 100.7%; Δ 3.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.74 (EBITDA TTM 312.0m / Interest Expense TTM 135.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.25
| (A) 0.16 = (Total Current Assets 1.28b - Total Current Liabilities 798.6m) / Total Assets 3.09b |
| (B) 0.16 = Retained Earnings (Balance) 485.2m / Total Assets 3.09b |
| (C) 0.07 = EBIT TTM 235.4m / Avg Total Assets 3.29b |
| (D) 0.22 = Book Value of Equity 725.0m / Total Liabilities 3.26b |
| Total Rating: 2.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.44
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 4.29% = 2.15 |
| 3. FCF Margin 7.11% = 1.78 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 7.01 = -2.50 |
| 6. ROIC - WACC (= 2.32)% = 2.90 |
| 7. RoE data missing |
| 8. Rev. Trend 19.88% = 1.49 |
| 9. EPS Trend 32.63% = 1.63 |
What is the price of SMG shares?
Over the past week, the price has changed by -1.24%, over one month by -3.64%, over three months by -0.06% and over the past year by -13.17%.
Is Scotts Miracle-Gro a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMG is around 54.10 USD . This means that SMG is currently overvalued and has a potential downside of -9.64%.
Is SMG a buy, sell or hold?
- Strong Buy: 7
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SMG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76 | 26.9% |
| Analysts Target Price | 76 | 26.9% |
| ValueRay Target Price | 58.9 | -1.7% |
Last update: 2025-09-12 04:45
SMG Fundamental Data Overview
CCE Cash And Equivalents = 51.1m USD (last quarter)
P/E Trailing = 75.2561
P/E Forward = 14.0449
P/S = 1.0356
P/B = 18.9789
P/EG = 0.2405
Beta = 1.962
Revenue TTM = 3.44b USD
EBIT TTM = 235.4m USD
EBITDA TTM = 312.0m USD
Long Term Debt = 2.14b USD (from longTermDebt, last quarter)
Short Term Debt = 52.1m USD (from shortTermDebt, last quarter)
Debt = 2.19b USD (Calculated: Short Term 52.1m + Long Term 2.14b)
Net Debt = 2.14b USD (from netDebt column, last quarter)
Enterprise Value = 5.70b USD (3.56b + Debt 2.19b - CCE 51.1m)
Interest Coverage Ratio = 1.74 (Ebit TTM 235.4m / Interest Expense TTM 135.1m)
FCF Yield = 4.29% (FCF TTM 244.6m / Enterprise Value 5.70b)
FCF Margin = 7.11% (FCF TTM 244.6m / Revenue TTM 3.44b)
Net Margin = 1.54% (Net Income TTM 53.1m / Revenue TTM 3.44b)
Gross Margin = 28.81% ((Revenue TTM 3.44b - Cost of Revenue TTM 2.45b) / Revenue TTM)
Tobins Q-Ratio = 7.86 (Enterprise Value 5.70b / Book Value Of Equity 725.0m)
Interest Expense / Debt = 1.45% (Interest Expense 31.7m / Debt 2.19b)
Taxrate = 28.08% (58.2m / 207.3m)
NOPAT = 169.3m (EBIT 235.4m * (1 - 28.08%))
Current Ratio = 1.61 (Total Current Assets 1.28b / Total Current Liabilities 798.6m)
Debt / EBITDA = 7.01 (Net Debt 2.14b / EBITDA 312.0m)
Debt / FCF = 8.95 (Debt 2.19b / FCF TTM 244.6m)
Total Stockholder Equity = -332.8m (last 4 quarters mean)
RoA = 1.72% (Net Income 53.1m, Total Assets 3.09b )
RoE = unknown (Net Income TTM 53.1m / Total Stockholder Equity -332.8m)
RoCE = 13.05% (Ebit 235.4m / (Equity -332.8m + L.T.Debt 2.14b))
RoIC = 8.14% (NOPAT 169.3m / Invested Capital 2.08b)
WACC = 5.82% (E(3.56b)/V(5.75b) * Re(8.75%)) + (D(2.19b)/V(5.75b) * Rd(1.45%) * (1-Tc(0.28)))
Shares Correlation 3-Years: 80.92 | Cagr: 0.50%
Discount Rate = 8.75% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.32% ; FCFE base≈545.9m ; Y1≈358.4m ; Y5≈163.9m
Fair Price DCF = 49.66 (DCF Value 2.87b / Shares Outstanding 57.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 32.63 | EPS CAGR: 89.71% | SUE: 1.21 | # QB: 1
Revenue Correlation: 19.88 | Revenue CAGR: 37.63% | SUE: -0.76 | # QB: 0
Additional Sources for SMG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle